Nautilus Biotechnology (NAUT) Total Liabilities (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Total Liabilities data on file, last reported at $33.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities changed 0.33% year-over-year to $33.4 million; the trailing twelve-month figure through Mar 2026 stood at $33.4 million (changed 0.33% YoY), and the FY2025 full-year result was $34.1 million, changed 0.37% from the prior year.
• Total Liabilities fell to $33.4 million in Q1 2026, from $34.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $42.2 million in Q1 2023 to a low of $31.8 million in Q3 2025.
• A 5-year average of $36.1 million and a median of $35.0 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 956.92% in 2022 and declined 15.42% in 2024, its largest moves.
• Tracing NAUT's Total Liabilities over 5 years: stood at $35.1 million in 2022, then gained by 14.47% to $40.2 million in 2023, then decreased by 15.42% to $34.0 million in 2024, then gained by 0.37% to $34.1 million in 2025, then retreated by 2.27% to $33.4 million in 2026.
• Business Quant data shows NAUT's Total Liabilities at $33.4 million in Q1 2026, $34.1 million in Q4 2025, and $31.8 million in Q3 2025.